Barclays Maintains Underweight on Eaton Corp, Lowers Price Target to $112
Barclays analyst Julian Mitchell maintains Eaton Corp (NYSE:ETN) with a Underweight and lowers the price target from $120 to $112.
Morgan Stanley Maintains Equal-Weight on Axsome Therapeutics, Raises Price Target to $54
Morgan Stanley analyst Vikram Purohit maintains Axsome Therapeutics (NASDAQ:AXSM) with a Equal-Weight and raises the price target from $27 to $54.
Barclays Maintains Overweight on Carrier Global, Lowers Price Target to $47
Barclays analyst Julian Mitchell maintains Carrier Global (NYSE:CARR) with a Overweight and lowers the price target from $50 to $47.
Morgan Stanley Maintains Overweight on Allegiant Travel, Lowers Price Target to $237
Morgan Stanley analyst Ravi Shanker maintains Allegiant Travel (NASDAQ:ALGT) with a Overweight and lowers the price target from $250 to $237.
UBS Maintains Buy on MPLX, Lowers Price Target to $40
UBS analyst Joseph Parkhill maintains MPLX (NYSE:MPLX) with a Buy and lowers the price target from $41 to $40.
UBS Maintains Buy on Carnival, Lowers Price Target to $12
UBS analyst Joseph Parkhill maintains Carnival (NYSE:CCL) with a Buy and lowers the price target from $23 to $12.
UBS Maintains Buy on Plains All American, Raises Price Target to $17
UBS analyst Joseph Parkhill maintains Plains All American (NASDAQ:PAA) with a Buy and raises the price target from $16 to $17.
JP Morgan Maintains Overweight on BlackRock, Lowers Price Target to $729
JP Morgan analyst Ken Worthington maintains BlackRock (NYSE:BLK) with a Overweight and lowers the price target from $902 to $729.
Wells Fargo Downgrades Audacy to Underweight, Lowers Price Target to $0
Wells Fargo analyst Steven Cahall downgrades Audacy (NYSE:AUD) from Equal-Weight to Underweight and lowers the price target from $2 to $0.
Piper Sandler Maintains Neutral on Moelis & Co, Lowers Price Target to $45
Piper Sandler analyst Jeffery Harte maintains Moelis & Co (NYSE:MC) with a Neutral and lowers the price target from $50 to $45.